Benjamin Balmforth
Venture investor in London
Invests in AIAI is one of the sectors on Benjamin Balmforth's investor profile, next to Healthcare & Biotech, Digital Health & HealthTech and MedTech & Medical Devices, at Series B. The record holds 59 deals, including Doctify, Nu Quantum and Axol Bioscience.
Email InvestorCredits to line up before a Series B round
Benjamin Balmforth backs companies at Series B. A few of the larger credit programs on AI Perks for teams at that point:
Portfolio on record
Portfolio companies
- Doctify
- Nu Quantum
- Axol Bioscience
- ScribbleLive
- Quibim
- Inotec AMD
- Secondmind
- Healx
- Senseon
- Veritas Intercontinental
- Ori Biotech
- PhoreMost
- Ravelin
- ContactEngine
- Monedo
- Immense
- FiveAI
- Seldon
- Baby2Body
- PolyAI
- Altana AI
- Igenomix
- Pimloc
- Sprout.ai
- Tailored.to
- Exonar
- Synthace
- miiCard
- Tessian
- Repositive
- XMOS
- Lumeon
- The ID Co.
- Congenica
- Descomplica
- V7
- iyzico
- Speechmatics
- Cambridge Touch Technologies Ltd.
- Zilingo
- Xampla
- Kontomatik
- XYZ Reality
- Riverlane
- Sphere Secure Workspace
- Hazy
- Paragraf
- brytlyt
- Pace
- Hepstar
Showing 50 of 59 deals on record.
Investment focus
- Backs startups in
- Artificial Intelligence, Healthcare & Biotech, Digital Health & HealthTech, MedTech & Medical Devices, Quantum & Semiconductors
- Rounds
- Series B
- Profile
- Venture investor
- Deals on record
- 59
- Based in
- London, United Kingdom
Ready to pitch AI investors?
AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.
Email InvestorMore AI investors on AI Perks
- Julia AndrePartner at Index Ventures
- Martin EricssonFounder & CEO at Priori Capital
- James WisePartner at Balderton
- Annalise DragicVenture investor in London
- Pierre SochaPartner at Amadeus Capital Partners
- Adam WorkmanVenture investor in Oxford
- Paul CockerVenture investor in the United Kingdom
- David HowellsVenture investor in Oxford
Questions founders ask
- Does Benjamin Balmforth invest in AI startups?
- Yes. Artificial Intelligence is one of the sectors on Benjamin Balmforth's investor profile, together with Healthcare & Biotech, Digital Health & HealthTech and MedTech & Medical Devices. The stages on record are Series B.
- Which companies has Benjamin Balmforth backed?
- The record lists 59 deals, including Doctify, Nu Quantum, Axol Bioscience, ScribbleLive and Quibim. None of them has a perk listed on AI Perks yet.
- What credits can a startup claim before pitching Benjamin Balmforth?
- For a company raising a Series B round, AI Perks lists credits such as Dynamics 365 (up to $5,000), SendGrid/Twilio (up to $10,000), Notion (up to $12,000) and CleverTap (up to $50,000), with each program's terms and how to apply.
- Does AI Perks publish investor contact details?
- No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor
Source: public professional information. Is this you? Request removal